Constitutive E2F1 Overexpression Delays Endochondral Bone Formation by Inhibiting Chondrocyte Differentiation

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2003 May 2

PMID 12724423

Citations 18

Authors

Blanca Scheijen

Marieke Bronk

Tiffany van der Meer

Rene Bernards

Affiliations

Soon will be listed here.

Abstract

Longitudinal bone growth results from endochondral ossification, a process that requires proliferation and differentiation of chondrocytes. It has been shown that proper endochondral bone formation is critically dependent on the retinoblastoma family members p107 and p130. However, the precise functional roles played by individual E2F proteins remain poorly understood. Using both constitutive and conditional E2F1 transgenic mice, we show that ubiquitous transgene-driven expression of E2F1 during embryonic development results in a dwarf phenotype and significantly reduced postnatal viability. Overexpression of E2F1 disturbs chondrocyte maturation, resulting in delayed endochondral ossification, which is characterized by reduced hypertrophic zones and disorganized growth plates. Employing the chondrogenic cell line ATDC5, we investigated the effects of enforced E2F expression on the different phases of chondrocyte maturation that are normally required for endochondral ossification. Ectopic E2F1 expression strongly inhibits early- and late-phase differentiation of ATDC5 cells, accompanied by diminished cartilage nodule formation as well as decreased type II collagen, type X collagen, and aggrecan gene expression. In contrast, overexpression of E2F2 or E2F3a results in only a marginal delay of chondrocyte maturation, and increased E2F4 levels have no effect. These data are consistent with the notion that E2F1 is a regulator of chondrocyte differentiation.

Citing Articles

Absence of E2f1 Negates Pro-osteogenic Impacts of p21 Absence.

Premnath P, Lun T, Siddiqui H, Stahl A, Ardebili A, Olsen A Calcif Tissue Int. 2024; 114(6):625-637.

PMID: 38643416 DOI: 10.1007/s00223-024-01210-7.

Functional Duality of Chondrocyte Hypertrophy and Biomedical Application Trends in Osteoarthritis.

Park S, Bello A, Arai Y, Ahn J, Kim D, Cha K Pharmaceutics. 2021; 13(8).

PMID: 34452101 PMC: 8400409. DOI: 10.3390/pharmaceutics13081139.

Genetic Markers Can Predict Chondrogenic Differentiation Potential in Bone Marrow-Derived Mesenchymal Stromal Cells.

Kanawa M, Igarashi A, Fujimoto K, Higashi Y, Kurihara H, Sugiyama M Stem Cells Int. 2018; 2018:9530932.

PMID: 30405725 PMC: 6199884. DOI: 10.1155/2018/9530932.

E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes.

Giralt A, Denechaud P, Lopez-Mejia I, Delacuisine B, Blanchet E, Bonner C Mol Metab. 2018; 11:104-112.

PMID: 29526568 PMC: 6001358. DOI: 10.1016/j.molmet.2018.02.011.

p21 mice exhibit enhanced bone regeneration after injury.

Premnath P, Jorgenson B, Hess R, Tailor P, Louie D, Taiani J BMC Musculoskelet Disord. 2017; 18(1):435.

PMID: 29121899 PMC: 5679350. DOI: 10.1186/s12891-017-1790-z.

References

Smits P, Li P, Mandel J, Zhang Z, Deng J, Behringer R . The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell. 2001; 1(2):277-90. DOI: 10.1016/s1534-5807(01)00003-x. View

Alkema M, van der Lugt N, Bobeldijk R, Berns A, van Lohuizen M . Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice. Nature. 1995; 374(6524):724-7. DOI: 10.1038/374724a0. View

Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y . Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res. 1997; 12(8):1174-88. DOI: 10.1359/jbmr.1997.12.8.1174. View

Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P . Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 1996; 84(6):911-21. DOI: 10.1016/s0092-8674(00)81069-7. View

Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M . Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol. 2001; 153(1):87-100. PMC: 2185519. DOI: 10.1083/jcb.153.1.87. View

Field S, Tsai F, Kuo F, Zubiaga A, Kaelin Jr W, Livingston D . E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 1996; 85(4):549-61. DOI: 10.1016/s0092-8674(00)81255-6. View

Serra R, Karaplis A, Sohn P . Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor beta (TGF-beta) on endochondral bone formation. J Cell Biol. 1999; 145(4):783-94. PMC: 2133184. DOI: 10.1083/jcb.145.4.783. View

Humbert P, Rogers C, Ganiatsas S, Landsberg R, Trimarchi J, Dandapani S . E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell. 2000; 6(2):281-91. DOI: 10.1016/s1097-2765(00)00029-0. View

Minina E, Wenzel H, Kreschel C, Karp S, Gaffield W, McMahon A . BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development. 2001; 128(22):4523-34. DOI: 10.1242/dev.128.22.4523. View

10.

Weir E, Philbrick W, Amling M, Neff L, Baron R, Broadus A . Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A. 1996; 93(19):10240-5. PMC: 38368. DOI: 10.1073/pnas.93.19.10240. View

11.

Minina E, Kreschel C, Naski M, Ornitz D, Vortkamp A . Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell. 2002; 3(3):439-49. DOI: 10.1016/s1534-5807(02)00261-7. View

12.

Naski M, Wang Q, Xu J, Ornitz D . Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet. 1996; 13(2):233-7. DOI: 10.1038/ng0696-233. View

13.

Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C . Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 1995; 9(19):2364-72. DOI: 10.1101/gad.9.19.2364. View

14.

Beijersbergen R, Kerkhoven R, Zhu L, Carlee L, Voorhoeve P, Bernards R . E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 1994; 8(22):2680-90. DOI: 10.1101/gad.8.22.2680. View

15.

Olsen B, Reginato A, Wang W . Bone development. Annu Rev Cell Dev Biol. 2000; 16:191-220. DOI: 10.1146/annurev.cellbio.16.1.191. View

16.

White A, Wallis G . Endochondral ossification: a delicate balance between growth and mineralisation. Curr Biol. 2001; 11(15):R589-91. DOI: 10.1016/s0960-9822(01)00359-1. View

17.

Bi W, Deng J, Zhang Z, Behringer R, de Crombrugghe B . Sox9 is required for cartilage formation. Nat Genet. 1999; 22(1):85-9. DOI: 10.1038/8792. View

18.

Wu L, Timmers C, Maiti B, Saavedra H, Sang L, Chong G . The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001; 414(6862):457-62. DOI: 10.1038/35106593. View

19.

Vooijs M, Jonkers J, Berns A . A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2001; 2(4):292-7. PMC: 1083861. DOI: 10.1093/embo-reports/kve064. View

20.

Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991; 108(2):193-9. DOI: 10.1016/0378-1119(91)90434-d. View